InvestorsHub Logo
icon url

JohnCM

11/28/18 11:18 AM

#410 RE: CornellEngineer #409

Typical report along with Curaleaf. Robust, accelerated earnings with a sizable loss.

I would suggest buying both this morning.

Shortsighted selling with an eye on the bottom line.